Biotech grants in Switzerland

Scheduled

Funds €7–10M programmes that bring better cancer diagnosis and treatment trials to patients across four or more European countries.

Scheduled

Funds three €5–7M projects that make cancer control more equitable, effective and cost-aware for patients and families.

Scheduled

Funds two €12M projects using living labs to remediate carcinogenic soils and trace cancer risks through people, food, water and air.

Scheduled

Funds €8–10M procurer consortia to bring affordable cancer technologies, devices and medicines from tender to patient benefit.

Scheduled

Funds one €3M coordination action that helps cancer charities and funders improve quality of life for young survivors across Europe.

Scheduled

Funds two €6M projects that use biotechnology to purify captured carbon and turn it into sustainable feedstock for industrial products.

Scheduled

Funds two €5M projects to use biotechnology to recycle complex plastics into high-value products at pilot scale across industrial value chains.

Scheduled

Funds €6M projects that turn bio-waste and secondary raw materials into safe, circular products, materials and value chains.

Scheduled

Funds €7–10M projects that advance living-cell bio-printing from laboratory proof toward regenerative medicine.

Scheduled

Funds a €3M coordination action that benchmarks emerging industrial bio-based systems for cleaner, circular and more competitive European value chains.

Scheduled

Funds three €4M research projects that replace hazardous biocidal actives with safer bio-based substances for wood and mosquito control.

Scheduled

Funds a European community and roadmap for trustworthy frontier AI models in healthcare.

Scheduled

Funds two €7–8M innovation projects that move food-system microbiome products from validated testing toward reliable EU-market scale-up.

Scheduled

Funds two projects to use livestock microbiomes for healthier animals, lower antimicrobial use and safer, more sustainable One Health systems.

Between cycles

Invests in scale-up ventures in digital, clean technology, and biotechnology through equity to accelerate commercialization pathways.

Between cycles

Funds innovative SME-led international R&D consortia through the Eurostars Call 12 grant process.

Between cycles

Funds advanced innovation projects advancing robotics and physical AI deep-tech initiatives toward scalable outcomes.

Between cycles

Invests in European deep-tech scale-up ventures with momentum needing capital for commercial expansion.

Between cycles

Runs students and early career scholars with mentoring support for CRF Postdoctoral Research Fellowship in biotechnology, medical technology, and synthetic biology.

Between cycles

Administers research teams and institutions for CRF Research Grant in biotechnology, medical technology, and synthetic biology.

Between cycles

Supports EIC beneficiaries' participation in major trade fairs across the EU, MENA and the US.

Between cycles

Funds early-stage deep tech startups developing solutions at TRL 4-5 in collaboration with industry partners through a 4-month co-creation programme.

Between cycles

Supports international consortia so small companies can turn joint innovation into export-ready products.

Between cycles

Offers market-feasibility support for small companies exploring non-European markets through Europe-wide innovation networks.